Table 2.
Baseline Characteristics | All Patients n = 60 |
Male n = 40 |
Female n = 20 |
---|---|---|---|
Age (years), median (range) | 56 (20–74) | 57 (20–71) | 47 (20–74) |
Body mass index, median (range) | 24.4 (15.9–45.5) | 26.4 (18.7–45.5) | 21.7 (15.9–41.1) |
Karnofsky index (percent), median (range) | 90 (50–100) | 90 (50–100) | 90 (50–100) |
Disease characteristics | All patients n = 60 |
||
Disease Prior therapy lines median (range) |
DLBCL (69%), ALL (15%), MCL (7%), CLL (3%), FL (3%), PMBCL (3%) 5 (2–10) |
||
Duration in-patient stay (days), median (range) | 20 (14–110) |
DLBCL = Diffuse large B-cell lymphoma, ALL = Acute lymphoblastic leukemia, MCL = Mantle cell lymphoma, CLL = chronic lymphocytic leukemia, FL = Follicular lymphoma, PMBCL = Primary mediastinal B-cell lymphoma.